RPD Intrinsic Valuation and Fundamental Analysis - Royalty Pharma PLC

R	Royalty Pharma PLC XBER:RPD	US
	Macmahon Holdings Ltd ASX:MAH	AU
A	Ameren Corp F:AE4	US
T	TOC Co Ltd XMUN:T3O	JP
	Cantargia AB STO:CANTA	SE
E	Empire State Realty Trust Inc F:ES9	US
P	Ppi Public Property Invest publ AB STO:PUBLI	SE
	Fagerhult AB F:2F0	SE
	Nedap NV F:NE3	NL
C	Carlos Casado SA BCBA:CADO	AR
	Chubb Ltd NYSE:CB	CH
P	Prudential PLC DUS:PRU	UK
	Modulight Oyj F:78W	FI
	Atlantic Sapphire ASA F:4AS	NO
	TNG Ltd ASX:TNG	AU
	Agrana Beteiligungs AG F:AGB2	AT
B	Brookdale Senior Living Inc XBER:B7S	US

Intrinsic Value

The intrinsic value for Royalty Pharma PLC (RPD) under the Base Case is hidden EUR. Compared with the current market price of 39.92 EUR, the stock appears hidden .

Intrinsic value calculated using Multiples

Locked

Other reference points

DCF valuation

Locked

Wall St target

€40.55

Do our valuations actually work? See backtest results .

RPD Intrinsic Value

Unlock

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price €39.92

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

RPD looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether RPD usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Royalty Pharma PLC.

Explain Valuation